MMJ Recs

DECEMBER 17, 2023

The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

SEPTEMBER 12, 2022

All Optimi mushroom products are grown from the Company’s world-leading psilocybin genetic bank and are grown in EU-GMP compliant clean rooms that ensure sterile cultivation and undergo almost 300 different analytical tests post-harvest. The harvest includes the following psilocybin-containing mushroom strains: Koh Samui. Penis Envy.

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

MAY 29, 2022

A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada. The psilocybin mushrooms are headed to clinical trials, drug companies and medical facilities. “I’m

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

JANUARY 12, 2022

Management’s decision to end all connections to the cannabis cultivation industry positions Gb Sciences to uplist its stock to a senior exchange and attract institutional investors and strategic partners in the biopharmaceutical drug development sector to accelerate its clinical development progress. 31, 2021.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

JULY 24, 2021

“At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer. The new patent filings are anticipated to populate the pipeline beyond MYCO-004. Mydecine has also successfully completed multiple acquisitions since its inception.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

MMJ Recs

APRIL 1, 2024

Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders. Exploring CBD for Medical Use As interest in CBD grows, researchers are continuously exploring its potential applications in the medical field.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

FEBRUARY 3, 2022

Together with its wide network of research partners, MediCane is executing clinical programs to develop cannabis-based drugs with two leading therapeutic areas – Behavioral and Psychological Symptoms of Dementia (BPSD) and sleep disorders. The company launched its manufacturing facility in Kfar Saba in 2020.

Clinical Trials 52

Clinical Trials Research and Development Packaging Oil 52

NORML

SEPTEMBER 20, 2019

But at the Vegas event, she brought good news: She announced that other universities would host her research, and she recently applied for a third-party cultivation license from the DEA, the only federal agency that can legally provide cannabis for clinical study in the US. The only problem is, the program doesn’t actually exist.

DEA 230

DEA Research and Development Clinical Trials Patients 230

Cannabis Law Report

MARCH 6, 2022

As clinical trials using psilocybin (from ‘magic mushrooms’) to treat depression, anxiety, addictions and end-of-life fear of death show that a high dose of the psychedelic together with therapy has enormous potential in lessening symptoms over extended periods of time.

Education 52

Education Clinical Trials Therapy Programs 52

Cannabis Law Report

FEBRUARY 9, 2022

Since then, Reset has commenced the construction of its stand-alone psilocybin mushroom cultivation facility, which is expected to be completed in the June 2022 quarter. LGP initially entered the psychedelic space in September last year after it received a licence to supply psilocybin from the Western Australian Department of Health.

Clinical Trials 52

Clinical Trials Research and Development Medicine Business 52

The Cannigma

MAY 19, 2021

Some hemp cultivation is permitted in Japan, but on a relatively very small scale. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. There is also a strong social stigma that surrounds cannabis use in Japan, and only an estimated 1.8%

Law 137

Law Legalization Clinical Trials CBD 137

SpeedWeed

JULY 31, 2021

More specifically, the Ohio Medical Marijuana Control program would remain intact, and licensed operators could pursue additional licenses to enter the adult-use market. And the bill would impose restrictions on the cultivation, processing, transportation and sale of cannabis.

Legalization 52

Legalization Clinical Trials Decriminalization Research and Development 52

Canna Law Blog

JANUARY 3, 2023

Until recently, CBD resided in a legal penumbra where hemp was still scheduled on the federal Controlled Substances Act and could not be cultivated without a permit from the Drug Enforcement Administration (“DEA”). It’s not like the FDA is unaware of the massive unregulated CBD market that already exists in the U.S.

CBD 75

CBD Food Clinical Trials Pets 75

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. The MDMA Therapy Training Program was created to train the next generation of psychedelic therapists. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 13, 2019

Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. We gave the option to foreign companies to cultivate in Denmark.”. Heitmann admitted there were challenges connected to being the first-mover in Big Pharma.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

SpeedWeed

AUGUST 16, 2021

We couldn’t be more thrilled to host Dr. Sisley at Cannabis Conference 2021 as our Day 2 keynote,” said Cannabis Conference Programming Director Cassie Neiden Tomaselli. “Dr. The Day 2 keynote session will take place on Wednesday, Aug. 25 from 11 a.m. – Sisley is the definition of a cannabis trailblazer. 24-26, 2021. About GIE Media.

Media 52

Media Clinical Trials DEA Hemp 52

Cannabis Law Report

SEPTEMBER 23, 2022

SB 57 – which passed both houses – would have created a pilot program for overdose prevention sites in San Francisco, Oakland, and Los Angeles as an evidence-based intervention to curb drug overdose deaths. Senator Wiener will look to re-enter both the overdose prevention and a revised psychedelic decriminalization bill next session.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

Canna Law Blog

MAY 7, 2020

Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968. This was before implementation of the federal government’s Compassionate Investigational New Drug Program (CINDP), which Ole Miss’s grow now serves in addition to its research.

DEA 71

DEA Research and Development Cultivation Supply Chain 71

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. Fortunately, the U.S. territories.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Legislation is pending, House Bill 5595, to permit the use, possession, cultivation, and retail sale of marijuana for adults 21 and over. Additionally, a bipartisan coalition of U.S.

Legislation 160

Legislation Decriminalization Access Therapy 160

WeedAdvisor

AUGUST 3, 2019

Domestic Cultivation and Products. . One issue on the table is the decision for large-scale domestic cultivation. Domestic cultivation is fairly straightforward – but still unpopular with opponents. Proponents argue the many benefits – especially economic ones – to bringing medicinal cannabis to the country. Opposition. .

Clinical Trials 51

Clinical Trials Cultivation Legislation Cannabis 51

Cannabis Law Report

MARCH 3, 2022

This was accomplished via the SVG Bureau of Standards creating a Scientific Research License that allows for the cultivation, processing, import/export of psychedelic compounds for medicinal purposes and scientific research. The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. and Europe.

Research and Development 52

Research and Development Medicine Clinical Trials Microdosing 52

The Cannigma

AUGUST 26, 2021

Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another. Medical: Legal Recreational: Illegal (though at least one territory has adopted decriminalization).

Legalization 52

Legalization Access Medicine Clinical Trials 52

Freedom Leaf

JANUARY 10, 2018

“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers. Growing operations.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

AUGUST 30, 2019

Americans for Safe Access released its 2018-2019 State-of-the-State report examining state laws and regulations surrounding Patient Rights and Civil Protection from Discrimination, Access to Medicine, Ease of Navigation, Functionality of the Programs, and Consumer Safety and Provider Requirements.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

SEPTEMBER 21, 2021

Hunter Neubauer, Co-Founder and Chairman of the Board at Oregrown, is a passionate and multifaceted leader focused on expanding Oregrown’s wholesale and distribution capabilities, cultivation efficiencies and business development opportunities. Are your legislators and the OLCC working on programs to further improve the sector? .

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

SpeedWeed

MARCH 5, 2021

Rescheduling cannabis will not necessarily facilitate clinical research.

Business 52

Business Policy Clinical Trials Research and Development 52

CannaMD

AUGUST 8, 2020

This new bill allows broad hemp cultivation. According to FDA Commissioner Scott Gottlieb : This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies. More recently, the 2018 Farm Bill expanded hemp legislation.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

JUNE 4, 2021

In 1996, California legalized medical cannabis yet today, with 37 US States allowing for medical cannabis sales, we still do not have an overall comprehensive cannabis/cannabinoid education program. Consumers, regulators, and legislators remain in the dark on cannabis.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

JUNE 30, 2019

New Mexico expands medical cannabis program to include protections against discrimination, reciprocity with other states’ medical programs, and three-year renewal cycle (up from one) for medial cannabis cards; and. Nebraska farmers looking to grow hemp this season have until 5 p.m. The panel also took up a bill sponsored by Rep.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Continued Protections for State Legal Medical Programs. California.

Legislation 59

Legislation Patients Access Banking 59

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. CBD candles and outdoor grow lights for home cultivation) are expected to embrace cannabis to various degrees.

Law 40

Law Seed-To-Sale Hemp Recreational 40

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. But what happens to the medical programs and access and probably in ways that I don’t even know what to ask?

Legalization 128

Legalization Patients Education Dispensary 128

SMPL

MAY 26, 2020

Near him was Stacey Kerr, a physician with flowing silver hair who served as treasurer of the Society of Cannabis Clinicians, as well as Wade Laughter, a soft-spoken man in glasses who had started cultivating pot for his glaucoma in the mid-90s. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

AUGUST 12, 2019

There are two main species of cannabis that are cultivated for human consumption, namely Cannabis indica and Cannabis sativa. Sativa plants are taller and produce more fiber and are therefore the species from which hemp cultivation arose. It is cultivated mainly for medicinal and “recreational” purposes. However, many U.S.

CBD 40

CBD Terpenes Oil Tincture 40